Joseph Irwin, a father of a child with a rare disease, explains the importance of data sharing in rare disease research.
We are delighted to report that the RD-Connect poster “RD-Connect: an integrated infrastructure for data sharing and analysis in rare disease research” is the winner of the poster display at the(…)
The last Annual Meeting in the current EU funding period focused on project’s achievements, plans for the future and sustainability.
This endorsement is a great achievement for RD-Connect and reflects its importance for the rare disease research.
On the Rare Disease Day, articles highlighting RD-Connect has been published in the EU “Horizon” magazine and in the Mexican “Nexos”.
Since 2018, the last day of February has been celebrated as the Rare Disease Day to raise awareness about rare diseases and their impact on patients’ lives. The campaign targets(…)
European Journal of Human Genetics has published a key publication describing the achievements of three flagship EU-funded projects – RD-Connect, NeurOmics and EURenOmics.
The European Commission’s Directorate-General for Research has published two articles presenting RD-Connect and EURenOmics as success stories. The articles, included among the Research and Innovation success stories, highlights project’s achievements(…)
RD-Connect would like to congratulate all the coauthors of the new publication on the RD-Connect Registry & Biobank Finder, published by the European Journal of Human Genetics.
We are delighted to announce that Dr Ivo Gut from the Centro Nacional de Análisis Genómico in Barcelona will serve as RD-Connect’s new scientific coordinator.
RD-Connect is delighted to play a major role in the exciting new Solve-RD project to use cutting-edge omics technologies to diagnose undiagnosed patients from ERNs.
The Rare Revolutions Magazine has published an article highlighting the work by RD-Connect.
This report summarizes the main achievements of RD-Connect in the 5th year of the project.
Are you a researcher working with disease mouse models? You can apply for the INFRAFRONTIER2020 mouse model development service to deliver novel mouse lines. Deadline: 20th of December 2017.